.

Phase two of Da Nang vaccinations to begin from April 26

By DA NANG Today / DA NANG Today
April 25, 2021, 11:47 [GMT+7]

The Da Nang Department of Health announced on Saturday morning that phase two of Da Nang vaccinations for the priority groups as guided by Viet Nam’s national government will begin on April 26 and end before May 15.

A total of 6,300 doses of the vaccine have been delivered for phase two of Da Nang’s vaccination programme by Vietnamese Ministry of Health as part of Viet Nam’s national COVID-19 immunisation programme to be rolled out in 19 cities and provinces nationwide since March 8.

The priority groups for phase two of Da Nang’s vaccination are frontline workers. Included are medical staff, and other frontliners who are currently helping in the fight against COVID-19 such as members of steering committees for COVID-19 prevention and control in all districts across the city, journalists and those working in designated isolation facilities.

Da Nang Department of Health Director Ngo Thi Kim Yen said that in its efforts to keep track of the progress of the Da Nang vaccination programme as its rollout progresses, the Da Nang Center for Disease Control and Prevention (CDC) has already developed a specific plan and made a list of eligible people for the vaccine in order to help the city best prepare for phase two of Da Nang’s vaccination.

The Da Nang CDC has also organised the COVID-19 vaccination training for health workers. Important has also been attached to ensuring best practices in vaccination sites in a bid to make operations more efficient.  

“Our healthcare staff will continue to follow up the people vaccinated in line with Ministry of Health’s regulations. The staff will monitor all vaccine recipients for any signs of allergic reactions,  including fever, skin rash, swelling, and respiratory symptoms within 24 hours, and lasting 7 days after vaccination”, said Director Yen.

According to the Vietnamese Ministry of Health, all vaccinated people are in safe condition.

Anticipated side effects were recorded in 33 percent of those receiving AstraZeneca shots, including redness at the injection site, fever, tiredness, nausea, and headache, but they were mostly mild and went away within one or two days without needing treatment.


Reporting by PHAN CHUNG – Translating by H.L

.
.
.
.